CHARLOTTE, N.C., May 06, 2016 (GLOBE NEWSWIRE) — John Wiesehan Jr., CEO of Mistic®, one of the largest independent makers of high quality, value-priced e-cigs and vapor products, today issued the following statement regarding the Food & Drug Administration’s (FDA) final deeming rule on e-cig and vapor product regulations:

“While we are currently reviewing the FDA’s final deeming regulations, which extend its product authority on the manufacturing and marketing of e-cigs, we always have supported sensible, science-based regulations of vapor products, including product standards, labeling requirements, bans on underage use and child-resistant packaging.

“Vapor products continue to offer a significant alternative to smokers, which is corroborated by top researchers in the field of tobacco harm reduction, including the U.K.’s Royal College of Physicians, one of the world’s leading medical institutions that recently endorsed vaping as a replacement tool for smoking.

“As one of the largest independent vapor companies, we believe we are well positioned to comply with the FDA’s regulations and already have taken many of the steps that would be required under the deeming process from manufacturing to labeling to marketing. However, it’s vital that the pathway to market for vapor product innovation is not stifled by an unduly approval process, such as a costly pre-market tobacco product application (PMTA).

“We take pride in the fact that we as an American company are creating jobs in this industry and that all of our e-liquids and the filling of our cartridges are developed in the U.S. in an ISO 8 class 100,000 clean room facility. We believe this positions us as a leader in the space and sets the stage for continued innovation in the category as new products are introduced, offering smokers a significant alternative to combustible cigarettes.

“Accordingly, we continue to support legislation to change the predicate date, as supported in H.R. 2058 (aka Cole Bill), as well as a bi-partisan amendment introduced by U.S. Representatives Tom Cole (R-OK) and Sanford Bishop (D-GA) that recently passed the House Appropriations Committee, so that a more viable substantial equivalency pathway to market of vapor products can be achieved.

“The Family Smoking Prevention and Tobacco Control Act was not legislatively constructed in 2009 to address marketplace innovation in the delivery of nicotine as our Mistic and HAUS products now present to adult consumers. We encourage the U.S. Senate to embrace the sensible predicate date solution taken by the House Appropriations Committee.”

About Mistic

Mistic® E-Cigs is an independent manufacturer of high-quality vapor products, primarily sold through brick-and-mortar retail channels under the direction of its parent company, Ballantyne Brands. The company’s Mistic brand of rechargeable and non-rechargeable e-cigarettes, including the Mistic Bridge™, as well as its HAUS™ line of vapor products, such as the HAUS™ Personal Vaporizer by Mistic and HAUS™ e-liquids, are sold in 70,000 retail outlets and wholesalers across the U.S., including Walmart, Walgreens, Dollar General, Kangaroo Express, Circle K, Hess, Speedway, Family Dollar, Winn Dixie/Bi-Lo and Food Lion, HT Hackney, McLane Company, Coremark, Nash Finch and Petrey. The company produces all of its e-liquid in the U.S., including the bottling and filling of its HAUS branded e-liquid bottles, as well as the filling and assembly of Mistic refill cartridges and starter packs.

For more information on the company, visit www.misticecigs.com and www.HAUSvape.com, follow on Twitter @MisticEcig and @HAUSpv, watch on YouTube, or like on Facebook at MisticElectronicCigarettes and HAUS.

 

CONTACT: Media Contact: PondelWilkinson George Medici | [email protected] (310) 279-5980

Vapor Products

Statement by John Wiesehan Jr., CEO of Mistic E-Cigs, Regarding the FDA’s Final Deeming Regulations of Vapor Products